Sort
21,281 grants matching “influenza”
DEVELOPMENT OF INFLUENZA SURVEILLANCE NETWORKS
$750,000Yuelong Shu · Natl Inst Of Viral Disease Control/Prev · U50 · FY2008 · CI
10th IAS Conference on HIV Science (IAS 2019), Mexico City, Mexico, 21-24 July 2019
$750,000Chris Beyrer · Ias · R13 · FY2019 · AI
RFA-IP-22-004, US Platform to Measure Effectiveness of Seasonal Influenza, COVID-19 and other Respiratory Virus Vaccines for the Prevention of Acute Illness in Ambulatory Settings
$749,999Emmanuel B Walter · Duke University · U01 · FY2025 · IP
Live Attenuated RSV Vaccine with Optimized Safety and Immunogenicity
$749,998Mark E. Peeples · Research Inst Nationwide Children'S Hosp · P01 · FY2015 · AI
Confocal microscope for a live cell imaging facility at biosafety level 2
$749,996Anne Hamacher-Brady · Johns Hopkins University · S10 · FY2024 · OD
High throughput camelid antibody screening as a drug discovery platform
$749,787Hiep T Tran · Abzyme Therapeutics, Llc · R44 · FY2017 · GM
A NOVEL STRATEGY TO INHIBIT SARS-COV-2 INFECTION AND COVID-19
$749,787Philippe Andre Gallay · Scripps Research Institute, The · R01 · FY2025 · AI
Tuberculosis Immunopathogenesis During Superinfection with SARS-CoV2
$749,747Adel M Talaat · University Of Wisconsin-Madison · R01 · FY2025 · AI
Effects of vitamin D and omega-3 fatty acids on infectious diseases and hCAP18
$749,734Carlos A. Camargo · Brigham And Women'S Hospital · R01 · FY2013 · AI
Development of a novel vaccine platform: Surface Antigen/Adjuvant Vaccine Engineering (SAAVE)
$749,669Michael Stephen Trent · University Of Georgia · R01 · FY2020 · AI
Recombinant Hyperimmune Gammaglobulin for Primary Immunodeficiency
$749,659David Scott Johnson · Gigagen, Inc. · R44 · FY2017 · AI
Administrative Core
$749,481Adolfo Garcia-Sastre · Icahn School Of Medicine At Mount Sinai · U19 · FY2014 · AI
IP20-003, Data driven transmission models to optimize influenza vaccination and pandemic mitigation strategies - COVID-19 Supplement
$749,360Jonathan L Zelner · University Of Michigan At Ann Arbor · U01 · FY2023 · IP
New Paradigms in Gene Regulation During Influenza Virus Infections
$749,229Curt M Horvath · Northwestern University · U01 · FY2010 · AI
Investigation of host glycan requirements for the transmission of influenza viruses at the human-animal interface
$749,159Balaji Manicassamy · University Of Iowa · R01 · FY2025 · AI
Discovery and validation of pan-influenza antivirals
$749,135Megan Louise Shaw · Icahn School Of Medicine At Mount Sinai · R56 · FY2018 · AI
EVASION OF HOST IMMUNE RESPONSE BY INFLUENZA VIRUS
$749,126Mount Sinai School Of Medicine Of Nyu · P01 · FY2000 · AI
IP20-003, Data driven transmission models to optimize influenza vaccination and pandemic mitigation strategies - COVID-19 Supplement
$748,899Jonathan L Zelner · University Of Michigan At Ann Arbor · U01 · FY2021 · IP
Development of vaccine approaches to elicit broadly protective influenza-specific immune responses in infants
$748,799Martha A. Alexander-Miller · Wake Forest University Health Sciences · R01 · FY2022 · AI
Annual Estimates of Influenza Vaccine Effectiveness for Preventing Laboratory-Con
$748,549Arnold S Monto · University Of Michigan At Ann Arbor · U18 · FY2010 · IP
IP20-003, Data driven transmission models to optimize influenza vaccination and pandemic mitigation strategies - COVID-19 Supplement
$748,470Jonathan L Zelner · University Of Michigan At Ann Arbor · U01 · FY2022 · IP
Deep sequencing of pathogens to precisely define transmission networks using rare variants
$748,381William Hanage · Harvard School Of Public Health · R01 · FY2018 · AI
Hospital and Household Studies of Respiratory Cryptosporidiosis and Transmission
$748,322Jeffrey K Griffiths · Tufts University Boston · R01 · FY2012 · AI
Systems immunology of influenza vaccination responses in healthy COVID-19 recovered individual versus those with no history of COVID-19
$748,298Rachel Sparks · National Institute Of Allergy And Infectious Diseases · ZIA · FY2023 · AI
Administrative Core
$748,106Yoshihiro Kawaoka · University Of Wisconsin-Madison · U19 · FY2015 · AI